The Effectiveness of Convalescent Plasma and Hyperimmune Immunoglobulin for the Treatment of Severe Acute Respiratory Infections of Viral Etiology: A Systematic Review and Exploratory Meta-analysis

Journal of Infectious Diseases - Tập 211 Số 1 - Trang 80-90 - 2015
John Mair-Jenkins1, María Saavedra-Campos2,3, J. Kenneth Baillie4, Paul Cleary2, Fu-Meng Khaw1, Wei Shen Lim5, Sophia Makki1, Kevin Rooney6, Jonathan S. Nguyen‐Van‐Tam7, Charles Beck7
1East Midlands Centre, Public Health England
2Field Epidemiology Service, Public Health England, Liverpool
3Field Epidemiology Training Programme, Public Health England, London
4Roslin Institute, University of Edinburgh, Midlothian
5Respiratory Medicine, Nottingham University Hospitals NHS Trust
6Institute of Care and Practice Improvement, University of the West of Scotland, Hamilton, United Kingdom
7Division of Epidemiology and Public Health, University of Nottingham, Nottingham

Tóm tắt

Từ khóa


Tài liệu tham khảo

World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV)—update (26 May 2014). http://www.who.int/csr/don/2014_05_23_mers/en/ Accessed 26 May 2014.

World Health Organization. Clinical management of severe acute respiratory infections when novel coronavirus is suspected: what to do and what not to do. http://www.who.int/csr/disease/coronavirus_infections/InterimGuidance_ClinicalManagement_NovelCoronavirus_11Feb13u.pdf Accessed 5 July 2014.

Public Health England, ISARIC. Treatment of MERS-CoV: decision support tool v.1.0. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317139281416 Accessed 18 October 2013.

The WHO MERS-CoV Research Group. State of knowledge and data gaps of middle east respiratory syndrome coronavirus (MERS-CoV) in humans. PLoS Curr Outbreaks 2013. pii: ecurrents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8.

10.1378/chest.12-2907

10.1007/s10096-005-0004-z

10.1371/journal.pmed.0030343

10.1093/jac/dki346

10.1093/jac/dkn243

10.1371/journal.pmed.1000097

Mair-Jenkins J Saavedra-Campos M Nguyen-Van-Tam J Beck C . Middle East Respiratory Syndrome Coronavirus (MERS-CoV) and the effectiveness of convalescent plasma for the treatment of severe acute respiratory infections of viral aetiology: a systematic review. PROSPERO 2013CRD42013005091. http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42013005091 Accessed 12 June 2013.

Cochrane handbook for systematic reviews of interventions. Version 5.1.0. Updated March 2011. Oxford, UK: The Cochrane Collaboration; 2011. http:www.cochrane-handbook.org Accessed 12 June 2013.

Tugwell P Wells G . The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp Accessed 20 June 2013.

West S King V Carey T Lohr K McKoy N Sutton S . Systems to rate the strength of scientific evidence: summary. Rockville, MD: Agency for Health Research and Quality; 2002.

Centre for Reviews and Dissemination. Systematic Reviews: CRD's guidance for undertaking reviews in health care. York: University of York; 2009.

10.1371/journal.pone.0029249

Bass J Ervin CE . Use of serum in the treatment of influenza-pneumonia. Nav Med Bull 1919:71-3.

Simici, 1922, Treatment of influenza with injections of blood from convalescents, Paris Med J, 43, 474

Jacobaeus, 1920, Treatment of influenza pneumonia with serum from convalescents, Sven Lakartidnin, 18, 385

Redden, 1919, Treatment of influenza pneumonia by use of convalescent human serum, Boston Med Surg J, 161, 688, 10.1056/NEJM191912111812406

10.7326/0003-4819-145-8-200610170-00139

10.1097/CCM.0b013e3182771386

Kong, 2006, Successful treatment of avian influenza with convalescent plasma, Hong Kong Med J, 12, 489

Wiesneth, 2010, Convalescent plasma for prophylaxis and treatment of severe pandemic influenza A (H1N1) 2009 infection: Case reports, Vox Sang, 99, 238

Wong, 2003, Treatment of severe acute respiratory syndrome with convalescent plasma, Hong Kong Med J, 9, 199

10.1056/NEJMc070359

Zhang, 2009, Clinical characteristics and therapeutic experience of case of severe highly pathogenic A/H5N1 avian influenza with bronchopleural fistula, Zhonghua Jie He He Hu Xi Za Zhi, 32, 356

10.1016/S1473-0502(03)00109-5

Wong, 2003, Treatment of severe acute respiratory syndrome with convalescent plasma, author reply, Hong Kong Med J, 9, 310

Chan, 2010, Hong Kong's experience on the use of extracorporeal membrane oxygenation for the treatment of influenza A (H1N1), Hong Kong Med J, 16, 447

10.1007/s10096-004-1271-9

Zhou, 2003, Epidemiologic features, clinical diagnosis and therapy of first cluster of patients with severe acute respiratory syndrome in Beijing area, Zhonghua Yi Xue Za Zhi, 83, 1018

10.1001/jama.1919.26110010013009d

10.1001/jama.1919.02610100017007

Huff-Hewitt, 1919, Human serum in influenza, Br Med J, 1, 575

10.1371/journal.pone.0002985

Sang, 2011, Retrospective study on collecting convalescent donors's plasma in treatment of patients with pandemic influenza A (H1N1) virus infection, Chin J Nosocomiology, 21, 4684

Gould, 1919, Human serum in the treatment of influenza bronchopneumonia, N Y Med J, 109, 666

Holst, 1919, Convalescent serum in treatment of influenza, Nor Mag Laegevidenskaben, 80, 531

Ehrenberg, 1919, Convalescent serum in the prevention and treatment of influenza, Hygiea, 81, 113

Lesne, 1919, Plasma therapy in influenza, Presse Med, 27, 181

Miller, 1919, Report of influenza treated with serum from recovered cases, Ky Med J, 17, 218

Bang, 1920, Convalescent serum in the treatment of influenza pneumonia, Nor Mag Laegevidenskaben, 81, 255

10.1056/NEJM192008051830609

Nie, 2003, Advances in clinical diagnosis and treatment of severe acute respiratory syndrome, World J Gastroenterol, 9, 1139, 10.3748/wjg.v9.i6.1139

10.1111/j.1469-0691.2004.00956.x

10.1001/jama.1919.02610020020007

10.1093/cid/ciq106

10.3947/ic.2009.41.5.265

10.1111/j.1537-2995.2010.02590.x